• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • News
  • Lifestyle
  • Wellness
  • Cuisine
  • Product Reviews
  • Subscribe
Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Emerald Media News Subscription
  • Print Magazines
  • 100+ Minority-Owned Companies to Support
  • No Pipe, No Problem
  • Blunt vs. Joint
  • The Cost of Cannabis in Each State
  • Calculating Your Edibles Dosage
  • Flintts Mouthwatering Mints

Study Suggests CBD Reduces Drug-Induced Cravings and Anxiety

April 28, 2020 by Melissa Hutsell 3 Comments

CBD reduces drug cravings

 

 

In the U.S., 128 people die everyday due to illicit or prescription opioid use, including oxycodone, heroin and fentanyl, reports the Center for Disease Control and Prevention (CDC). Such opioids are responsible for “46,802 overdose deaths in 2018” alone, or over 69% of “all drug overdose deaths” in America.  

Despite the public health crisis, there’s a lack of research on non-toxic alternatives.

At the same time, more Americans are turning to cannabis for pain management.

Those factors motivated a group of scientists to investigate CBD’s effect on opioid use. They were particularly keen to determine whether or not patients could use CBD to safely treat heroin use disorder. The disorder is defined by the American Psychiatric Association as, “a problematic pattern of opioid use leading to clinically significant impairment or stress.”

More specifically, the study set out to investigate CBD’s potential, “to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with [the disorder],” the authors wrote. 

Results, published in the American Journal of Psychiatry in May 2019, proved promising.



Trial and Triggers

The trail involved 42 “drug-abstinent” participants. On average, they used heroin for 10 years. The majority didn’t use drugs for just under month prior to the study. Researchers randomly gave each former user a 400mg or 800mg dosage of CBD, or a placebo. They took it once per day for three days. 

While the study did not specify what type of CBD was used, the Research Recovery Institute (RRI), a nonprofit located at the Harvard-affiliated Massachusetts General Hospital, reports that the prescription drug, Epidiolex, was used in the trial. The FDA approved the CBD-only medication in 2018 to treat seizures. 

After administration of the CBD/placebo, researchers exposed participants to neutral cues, and drug-use triggers at several different points: one hour, three hours, 24 hours, three days, and again after seven days. Neutral cues included three minute videos of nature, while triggers included videos of people using drugs. 

Researchers also tested participants’ heart rates, brain function, and cortisol levels. 



"A Strong Basis for Further Investigation"  

Those who took CBD experienced a significant reduction in cravings and anxiety brought on by negative triggers, found researchers. The effects lasted for an impressive seven days after their final dosages. Notably, there were no major differences between lower and higher doses of CBD. 

The study also found, “CBD reduced the drug cue–induced [...] heart rate and salivary cortisol levels. There were no significant effects on cognition, and there were no serious adverse effects.” Therefore, the cannabinoid "provides a strong basis for further investigation," authors wrote. 

While promising, the researchers hesitated to promote “medical marijuana,” according to the RRI. The authors also noted that the trial only examined the effects of Epidiolex for one week. Therefore, more research, particularly on long-term effects, are needed before the U.S. enters yet another wave in the opioid epidemic. 

 


Trump and DEA: Cracking Down on Opioids, Warming up to Cannabis

Filed Under: Wellness Tagged With: anxiety, CBD, cbdhealth, cbdoil, cravings, drug use, Epidiolex, health, hemp, heroin, Medical Cannabis, opioids, pain, placebo, stress, wellness

Reader Interactions

Comments

  1. Mike says

    September 23, 2022 at 11:18 pm

    WHOLE PLANT, not isolates or distillates, medicine is good but generic isolate CBD is not as good 🙂

    WHOLE PLANT CBD MEDICINE: there are more than 60 TYPES OF CBD BUT people continue to think CBD is ONE THING but there are many kinds of CBDs 🙂

    More than 60 flowers to choose from 🙂

    CBD is NOT a monolith but people continue to talk about it as if it were 🙁

  2. Mike says

    January 30, 2023 at 7:38 pm

    To stop drugs we need to WANT TO STOP and then we need WHOLE PLANT medicines to attract beneficial microflora to our brains and gut microbiomes to push the need from the front of our heads to the back hopefully and good luck with replacing chemical reactions in our bodies with botanical medicines titrated carefully please 🙂

  3. Mike says

    March 16, 2023 at 7:17 pm

    Please help END VACCINE ADDICTION with WHOLE PLANT medicines 🙂
    “Chemical free” to the best of our abilities and without punishing ourselves please 🙂

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Advertise Here

Categories

Sustainability

seaweed naturals

SeaWeed Naturals Combines the Power of Seaweed with Cannabis to Further Ocean Restoration

April 3, 2022 By Maggie Horton

fungi climate change

Research Finds Fungi Help Ease Climate Change and Benefit the Environment

March 30, 2022 By Julia Meyer

climate crisis and the pandemic

“We Can Act:” What Bending the COVID-19 Curve Teaches Us About the Climate Crisis

April 21, 2020 By Melissa Hutsell

Footer

  • Subscribe
  • About
  • Contact
  • Privacy
  • Press

Recent

  • Up in Smoke: An Interview with Smoke Proper, the Trailblazing Cannabis Accessory Brand
  • Priscilla Vilchis and Lil Kim Launch Aphrodisiak: A Cannabis Brand Focused on Sensuality, Social Justice, and Inclusivity
  • First Latina CEO of a Cannabis Company Partners with Music Industry Trailblazer Lil Kim to Launch Aphrodisiak Brand
  • Aphrodisiak: The New Female-Led Cannabis Brand Empowering Women and Promoting Inclusivity
  • Las Vegas Welcomes Aphrodisiak

Search

Copyright © 2023 · The Emerald™ · News & Lifestyle Magazine

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cannabis News and Culture Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.